The neuromuscular junction and wide heterogeneity of congenital myasthenic syndromes

The neuromuscular junction and wide heterogeneity of congenital myasthenic syndromes

Congenital myasthenic syndromes (CMS) are genetic disorders characterised by impaired neuromuscular transmission. This review provides an overview on CMS and highlights recent advances in the field, including novel CMS causative genes and improved therapeutic strategies. CMS due to mutations in SLC5...

ver descrição completa

Detalhes bibliográficos
Principais autores:	Rodríguez Cruz, P, Palace, J, Beeson, D
Formato:	Journal article
Idioma:	English
Publicado em:	MDPI 2018

Registros relacionados

Congenital myasthenic syndromes and the neuromuscular junction.
por: Cruz, P, et al.
Publicado em: (2014)

Congenital myasthenic syndromes and the formation of the neuromuscular junction
por: Beeson, D, et al.
Publicado em: (2008)

Congenital myasthenic syndromes and the formation of the neuromuscular junction.
por: Beeson, D, et al.
Publicado em: (2008)

Congenital myasthenic syndromes and the formation of the neuromuscular junction
por: Beeson, D
Publicado em: (2008)

The congenital myasthenic syndromes.
por: Palace, J, et al.
Publicado em: (2008)

Congenital myasthenic syndromes.
por: Beeson, D, et al.
Publicado em: (1997)

Congenital myasthenic syndromes: an update.
por: Finlayson, S, et al.
Publicado em: (2013)

The role of Rapsyn in neuromuscular junction and congenital myasthenic syndrome
por: Xufeng Liao, et al.
Publicado em: (2023-09-01)

The spectrum of mutations that underlie the neuromuscular junction synaptopathy in DOK7 congenital myasthenic syndrome.
por: Cossins, J, et al.
Publicado em: (2012)

Therapeutic strategies for congenital myasthenic syndromes
por: Lee, M, et al.
Publicado em: (2018)

Congenital myasthenic syndromes: Epidemiology, clinical phenotyping and aids to diagnosis in the neuromuscular clinic
por: Healy, E, et al.
Publicado em: (2014)

CLINICAL FEATURES OF THE SLOW-CHANNEL CONGENITAL MYASTHENIC SYNDROME
por: Lashley, D, et al.
Publicado em: (2009)

Inherited disorders of the neuromuscular junction: an update.
por: Rodríguez Cruz, P, et al.
Publicado em: (2014)

The genetic diagnosis of congenital myasthenic syndromes (CMS)
por: Man, S, et al.
Publicado em: (2005)

Ephedrine treatment in congenital myasthenic syndrome due to mutations in DOK7.
por: Lashley, D, et al.
Publicado em: (2010)

Synaptic dysfunction in congenital myasthenic syndromes.
por: Beeson, D
Publicado em: (2012)

Congenital myasthenic syndromes: recent advances
por: Beeson, D
Publicado em: (2016)

A nationwide service for the diagnosis and treatment of congenital myasthenic syndromes
por: Burke, G, et al.
Publicado em: (2006)

DOK7 congenital myasthenic syndrome.
por: Palace, J
Publicado em: (2012)

Clinical and experimental observations in patients with congenital myasthenic syndromes.
por: Vincent, A, et al.
Publicado em: (1993)

Clinical and experimental observations in patients with congenital myasthenic syndromes.
por: Vincent, A, et al.
Publicado em: (1993)

Muscle magnetic resonance imaging in congenital myasthenic syndromes
por: Finlayson, S, et al.
Publicado em: (2016)

Animal models of the neuromuscular junction, vitally informative for understanding function and the molecular mechanisms of congenital myasthenic syndromes
por: Webster, R
Publicado em: (2018)

Effect of β2-adrenergic receptor agonists on neurotransmission and neuromuscular junction structure in congenital myasthenic syndromes
por: Vanhaesebrouck, A
Publicado em: (2018)

Slow channel congenital myasthenic syndrome responsive to a combination of fluoxetine and salbutamol.
por: Finlayson, S, et al.
Publicado em: (2013)

Clinical features of congenital myasthenic syndrome due to mutations in DPAGT1
por: Finlayson, S, et al.
Publicado em: (2013)

Clinical features of congenital myasthenic syndrome due to mutations in DPAGT1.
por: Finlayson, S, et al.
Publicado em: (2013)

Congenital myasthenic syndromes in childhood: diagnostic and management challenges.
por: Kinali, M, et al.
Publicado em: (2008)

Congenital myasthenic syndrome caused by mutations in DPAGT.
por: Klein, A, et al.
Publicado em: (2015)

THE CLINICAL PHENOTYPIC SPECTRUM OF GFPT1 ASSOCIATED CONGENITAL MYASTHENIC SYNDROME
por: Chaouch, A, et al.
Publicado em: (2012)

Congenital myasthenic syndromes: Report of 7 Chile
por: Kleinsteuber, K, et al.
Publicado em: (2003)

AN UNUSUAL CASE OF CONGENITAL MYASTHENIC SYNDROME: THE MECHANISM FOR TREATMENT RESPONSE
por: Spillane, J, et al.
Publicado em: (2012)

Identification of DPAGT1 as a new gene in which mutations cause a congenital myasthenic syndrome.
por: Belaya, K, et al.
Publicado em: (2012)

Congenital Myasthenic Syndromes
por: J Gordon Millichap
Publicado em: (1994-01-01)

Therapy of myasthenic syndrome
por: Palace, J
Publicado em: (2012)

Congenital myasthenic syndromes
por: Josef Finsterer
Publicado em: (2019-02-01)

Congenital myasthenic syndrome due to mutations in MUSK suggests that the level of MuSK phosphorylation is crucial for governing synaptic structure
por: Rodríguez Cruz, PM, et al.
Publicado em: (2019)

Congenital Myasthenic Syndrome
por: WANG Wenqing, et al.
Publicado em: (2022-04-01)

New diagnosis in Chilean population: congenital myasthenic syndromes
por: Kleinsteuber, K, et al.
Publicado em: (2005)

Dok-7/MuSK signaling and a congenital myasthenic syndrome.
por: Yamanashi, Y, et al.
Publicado em: (2008)